FDA Approves Updated COVID Vaccines for 2026 | Tampa News

FDA just approved updated COVID-19 vaccines for the 2026-27 season, specifically targeting the dominant XFG (Stratus) variant now responsible for 79% of U.S. cases. Developed by Moderna, Novavax-Sanofi, and Pfizer-BioNTech—using mRNA or protein-based tech—the shots aim to combat rising infections fueled by school returns, travel, and uneven vaccine coverage. The variant, first spotted in Southeast Asia in January, arrived in the U.S. this spring. With last year’s vaccines focused on LP.8.1, this update is critical as public health officials urge vaccination plus basic hygiene to stay protected through fall. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/eb487e0190af1c59